International audience
-
November 3, 2017 (v1)PublicationUploaded on: March 25, 2023
-
September 3, 2018 (v1)Journal article
Objective To report the clinicopathologic features and outcome of myositis in patients treated with immune checkpoint inhibitors (ICIs) (irMyositis). Methods We retrospectively analyzed patients diagnosed with irMyositis in tertiary centers in Paris, France, and Berlin, Germany, from January 2015 to July 2017. The main outcomes were clinical...
Uploaded on: December 3, 2022 -
September 1, 2020 (v1)Journal article
Importance: Since 2011, many patients with metastatic melanoma have been treated with ipilimumab therapy and have developed severe immune-related adverse events (AEs). Because several immune therapies are now available to treat metastatic melanoma, a better knowledge of mechanisms and recurrence risks of immune-related AEs is needed before...
Uploaded on: December 3, 2022